Tarsus Pharmaceuticals, Inc. ( (TARS) ) has released its Q3 earnings. Here is a breakdown of the information Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals Inc ( NASDAQ:TARS) secured additional commercial coverage and two large Medicare contracts, covering more than 80% of patient lives. The company launched a direct-to-consumer ...

Adding pharmacists to primary care practices increases the primary care workforce because pharmacists can provide many ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...

Democratic Party leaders and their donors bear responsibility for the increasingly widespread view of trans rights as ...

The Democratic Party has become, improbably, the preferred party of American capital. But in doing so, it’s lost more and ...

States may be getting ready to crack down even harder on pharmacy benefit managers ... One NAIC panel, the Regulatory Framework Task Force, plans to hear a presentation on PBM transparency initiatives ...

Mark Cavendish began his career as a professional rider back in 2006 when he joined the T-Mobile squad after completing a ...

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.